ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,881Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 2056

$629K Total Retail Price of All Prescriptions

Rank: 28 out of 2056

432 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

22% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,862 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 525 363 1 1
OXYCODONE HCL 488 139 S2 2 24
HYDROCODONE-ACETAMINOPHEN 431 233 S3 3 5
METOPROLOL TARTRATE 355 259 4 11
FUROSEMIDE 343 245 5 9
LEVOTHYROXINE SODIUM 335 225 6 3
SIMVASTATIN 325 229 7 2
OMEPRAZOLE 268 169 8 4
AMLODIPINE BESYLATE 261 207 9 6
POTASSIUM CHLORIDE 225 179 10 18
METFORMIN HCL 213 144 11 8
GABAPENTIN 200 103 12 14
TRAMADOL HCL 200 92 12 27
ATORVASTATIN CALCIUM 177 102 14 17
RANITIDINE HCL 168 56 15 22
HYDROCHLOROTHIAZIDE 166 106 16 7
SERTRALINE HCL 142 61 17 25
WARFARIN SODIUM 130 105 18 12
BUMETANIDE 121 97 19 162
CITALOPRAM HBR 119 62 20 15
ZOLPIDEM TARTRATE 116 33 21 23
ATENOLOL 115 72 22 10
OXYCODONE-ACETAMINOPHEN 113 25 S2 23 40
METOPROLOL SUCCINATE 111 77 24 19
CRESTOR 108 82 25 30
CYCLOBENZAPRINE HCL 100 26 R 26 52
GLIPIZIDE 100 49 26 39
METHADONE HCL 93 0 S2 28 49
CARVEDILOL 93 86 28 35
PROAIR HFA 90 48 30 29
TRAZODONE HCL 85 33 31 21
OXYBUTYNIN CHLORIDE 84 54 32 79
CARISOPRODOL 83 0 R 33 97
NEXIUM 83 58 33 71
CLOPIDOGREL 79 67 35 72
CEPHALEXIN 78 41 36 125
DONEPEZIL HCL 76 64 37 37
NAPROXEN 75 61 38 84
LOSARTAN POTASSIUM 72 44 39 13
BACLOFEN 71 39 40 86
ISOSORBIDE DINITRATE 70 70 41 309
PROMETHAZINE HCL 68 0 R 42 127
LOVASTATIN 66 13 43 16
DOXEPIN HCL 63 0 44 200
GEMFIBROZIL 60 36 45 108
PANTOPRAZOLE SODIUM 60 44 45 55
SPIRIVA 59 38 47 42
METHOCARBAMOL 59 0 R 47 65
POLYETHYLENE GLYCOL 3350 58 38 49 50
ESCITALOPRAM OXALATE 58 29 49 118
PLAVIX 57 46 51 131
CYMBALTA 56 0 52 59
SPIRONOLACTONE 56 34 52 63
MIRTAZAPINE 55 40 54 45
AMITRIPTYLINE HCL 53 14 R 55 60
MORPHINE SULFATE ER 52 20 S2 56 36
PHENYTOIN SODIUM EXTENDED 50 21 57 143
IBUPROFEN 50 14 57 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.